Brett R. Hagen - Chief Accounting Officer at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Issuer Symbol
KLRS on Nasdaq
All Insider Reports
All Insider Reports

Brett R. Hagen - trading volume in the past year for Kalaris Therapeutics, Inc.

Holdings reported by Brett R. Hagen for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,925 $17,266 $8.97 26 Mar 2025 Direct
Stock Option (Right to Buy) 50,262 10 Apr 2025 Direct Common Stock

Transactions reported by Brett R. Hagen for Kalaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.